BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Ebola outbreak
    • Hantavirus
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Wednesday, May 27, 2026
Home » Topics » Infection » Coronavirus

Coronavirus
Coronavirus RSS Feed RSS

Regulatory front for Feb. 2, 2021

Feb. 2, 2021
By Mark McCarty
The latest global regulatory news, changes and updates affecting medical devices and technologies, including: CDC reports on cases, sequencing; NICE says savings seen with Cytosorb; IP at issue as WTO pushes for global pandemic effort; Researcher gets prison time for trade secret theft; USPTO responds to COVID-19 challenge.
Read More

Other news to note for Feb. 2, 2021

Feb. 2, 2021
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Accuvein, Adapthealth, Aerocare, Aegea Medical, Biosig, Cardiofocus, Chronix, Coopersurgical, Diagnos, Electrocore, Evestra, Geniemd, Horiba, Intellatriage, Japan Lifeline, Kanhoor Medical, Lidco, Masimo, Mayo Clinic, Medtest, Myriad Genetics, Novacyt, Omega Laboratories, Oncocyte, Predictive Oncology, Vivos Therapeutics.
Read More

Sputnik V vaccine efficacy confirmed, as developers tout safety, ease of distribution

Feb. 2, 2021
By Nuala Moran
LONDON –The Russian COVID-19 vaccine Sputnik V now has validation from the Western science establishment, after The Lancet published full interim results of the phase III trial on Feb 2. The peer-reviewed paper confirms the 91%-plus efficacy that the vaccine’s developer, Gamaleya National Center of Epidemiology and Microbiology, claimed in its own announcement of the results in December.
Read More
Regulatory front

IP at issue as WTO pushes for global pandemic effort

Feb. 2, 2021
By Mari Serebrov
The latest global regulatory news, changes and updates affecting biopharma, including: Researcher gets prison time for trade secret theft; USPTO responds to COVID-19 challenge.
Read More

Regulatory actions for Feb. 2, 2021

Feb. 2, 2021
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Bayer, BMS, Cerecor, Chinook, Durect, Kintor, Mustang, Neurmedix, Paxmedica, Russian Direct Investment Fund, Sesen, SQZ, VBI Vaccines.
Read More

Other news to note for Feb. 2, 2021

Feb. 2, 2021
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Adagene, Adamas, Adverum, Aeterna, Aikido, Annovis, Ascentage, Bharat Biotech, Biovaxys, Can-Fite, Cevec, Circ, Coherus, Engrail, Evozyne, Exelixis, Genentech, Harbour Biomed, Ilias, Immunome, Junshi, Maia, Mati, Max, Moleculin, Neurocycle, Novelion, Ocugen, Ono, Oragenics, Paragon, Probiogen, Q, Regeneron, Ribon, Rznomics, Viewpoint Molecular, Virios, X-Chem, Zebiai, Zydus.
Read More

In the clinic for Feb. 2, 2021

Feb. 2, 2021
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Abpro, Arch, Arena, Biomx, BMS, Bridgebio, Calcimedica, Cassava, Chemomab, Curis, Daiichi, Diurnal, Exonate, Gedea, Gemini, Immunovant, Janssen, Kira, Pharnext, Pinteon, RDIF, Secura, Selva, Tiziana, Travere, Verona.
Read More

Other news to note for Feb. 1, 2021

Feb. 2, 2021
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Arcus, Aicuris, Algernon, Akari, Biontech, Cognition, Curevac, Dynavax, Eversana, Gilead, Gritstone, Iterum, Kamada, Metrion, Noveome, Nyrada, Pfizer, Rentschler, Sonnet, Sosei, Sumitomo Dainippon, Titan, Valneva, Vir.
Read More
Digital imaging technology

NICE publishes guidelines for AI use in select imaging procedures

Feb. 1, 2021
By Nuala Moran
LONDON – The U.K. National Institute for Health and Care Excellence (NICE) has published new advice on how and when artificial intelligence (AI) could be applied to the interpretation of mammograms and chest computer tomography images, in a move that is intended to set the ground rules for the uptake of these technologies. In population breast screening, NICE looked at how five AI systems could be used to pick out mammography images that need further assessment, supporting qualified radiologists in their interpretation.
Read More

Other news to note for Feb. 1, 2021

Feb. 1, 2021
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Alivecor, Althea UK and Ireland, Ambu, Ascensia, Avails Medical, Cadwell Industries, Cardiovascular Systems, Chansu Vascular Technologies, Circularity Healthcare, Earlysense, Fuse Medical, Hillrom, Innova Medical Group, Laborie Medical Technologies, Mayo Clinic, Orthovestments, Roche, Seegene, Senseonics, Setpoint Medical, Urotronic.
Read More
Previous 1 2 … 291 292 293 294 295 296 297 298 299 … 552 553 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for May 26, 2026.
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for May 26, 2026
  • Microscopy of a cross-section of mouse skin containing melanoma tumors

    Researchers identify innate immune barrier against melanoma

    BioWorld
    Australian researchers have identified a previously overlooked population of immune cells in the skin that physically restrain melanoma growth by engulfing live...
  • In the clinic for May 26, 2026

    BioWorld
    Clinical updates for biopharma and med tech, including data readouts and publications: 858, A2 Biotherapeutics, AC Immune, Agendia, Agenus, Aktis, Ascentage,...
  • Cavalon Therapeutics and Northwestern patent new Cav1.3 blockers

    BioWorld Science
    Cavalon Therapeutics Inc. and Northwestern University have disclosed new voltage-gated calcium channel Cav1.3 blockers potentially useful for the treatment of...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing